Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or CabozantinibRoberto Iacovelli, Giuseppe Procopio, Chiara Ciccarese et al.|Clinical Genitourinary Cancer|2022Cited by 9
Phase II study of axitinib intensification compared to nivolumab alone after induction with ipilimumab plus nivolumab in patients with mRCC without previous complete response (AxIn study).Chiara Ciccarese, Roberto Iacovelli, Fabio Calabrò et al.|Journal of Clinical Oncology|2024Cited by 0